149 related articles for article (PubMed ID: 6684454)
1. Effect of oral CDP-choline on experimental withdrawal syndrome.
Tornos ME; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
Tornos ME; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1026-9. PubMed ID: 6684457
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
Tornos ME; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral CDP-choline on acrylamide-induced lesion.
Agut J; Font E; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1029-33. PubMed ID: 6684458
[TBL] [Abstract][Full Text] [Related]
5. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
Agut J; Font E; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
[TBL] [Abstract][Full Text] [Related]
6. CDP-choline: acute toxicity study.
Grau T; Romero A; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1033-4. PubMed ID: 6684459
[TBL] [Abstract][Full Text] [Related]
7. Study on the protection of CDP-choline against nicotine intoxication.
Grau T; Romero A; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1025-6. PubMed ID: 6684456
[TBL] [Abstract][Full Text] [Related]
8. Radioactivity incorporation into different cerebral phospholipids after oral administration of 14C methyl CDP-choline.
Agut J; Font E; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1048-50. PubMed ID: 6684464
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic dyskinesia with CDP-choline.
Arranz J; Ganoza C
Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
[TBL] [Abstract][Full Text] [Related]
10. CDP-choline: 6-month study on toxicity in dogs.
Romero A; Grau T; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1038-42. PubMed ID: 6684461
[TBL] [Abstract][Full Text] [Related]
11. Morphine physical dependence in the dog.
Martin WR; Eades CG; Thompson WO; Thompson JA; Flanary HG
J Pharmacol Exp Ther; 1974 Jun; 189(3):759-71. PubMed ID: 4858404
[No Abstract] [Full Text] [Related]
12. [Effect of psychotropic agents on the manifestation of the morphine abstinence syndrome in mice].
Patkina NA; Evartau EE
Farmakol Toksikol; 1980; 43(1):19-23. PubMed ID: 7189719
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
Lozano Fernández R
Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of methyl-14C CDP-choline by oral route.
Agut J; Font E; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
[TBL] [Abstract][Full Text] [Related]
15. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
[TBL] [Abstract][Full Text] [Related]
16. Study of subacute toxicity of CDP-choline after 30 days of oral administration to rats.
Romero A; Grau T; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1035-8. PubMed ID: 6684460
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
18. CDP-choline: repeated oral dose tolerance studies in adult healthy volunteers.
Dinsdale JR; Griffiths GK; Castelló J; Maddock J; Ortiz JA; Aylward M
Arzneimittelforschung; 1983; 33(7A):1061-5. PubMed ID: 6684468
[TBL] [Abstract][Full Text] [Related]
19. Establishment of physical dependence mice by oral ingestion of morphine.
McMillan DE; Waddell FB; Cathcart CF
J Pharmacol Exp Ther; 1974 Sep; 190(3):416-9. PubMed ID: 4472104
[No Abstract] [Full Text] [Related]
20. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
